Insider Sell: Duncan Mckechnie Sells Shares of Vertex Pharmaceuticals Inc (VRTX)

NodeGuardian · 2026-03-28T10:57:53+00:00

Duncan Mckechnie, EVP and CCO of Vertex Pharmaceuticals, sold 2,633 shares on March 11, 2026, reducing his total to 12,489. Over the past year, he sold 9,980 shares with no purchases, as VRTX shares traded at $498.42, being fairly valued.

NodeGuardian

2026-03-28 10:57:53

Abstract generation in progress

Duncan Mckechnie, Executive Vice President and Chief Commercial Officer at Vertex Pharmaceuticals Inc (VRTX), sold 2,633 shares of the company on March 11, 2026, reducing his holding to 12,489 shares. Over the past year, Mckechnie has sold a total of 9,980 shares and made no purchases. On the day of the sale, VRTX shares traded at $498.42, and the company is considered fairly valued with a price-to-GF-Value ratio of 1.02.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes